Cardiac MRI-derived Extracellular Volume Fraction versus Myocardium-to-Lumen R1 Ratio at Postcontrast T1 Mapping for Detecting Cardiac Amyloidosis.
Cardiac
Cardiomyopathies
Heart
MR Imaging
Journal
Radiology. Cardiothoracic imaging
ISSN: 2638-6135
Titre abrégé: Radiol Cardiothorac Imaging
Pays: United States
ID NLM: 101748663
Informations de publication
Date de publication:
Apr 2023
Apr 2023
Historique:
received:
26
12
2022
revised:
02
03
2023
accepted:
14
03
2023
medline:
1
5
2023
pubmed:
1
5
2023
entrez:
1
5
2023
Statut:
epublish
Résumé
To evaluate the diagnostic performance of myocardium-to-lumen R1 (1/T1) ratio on postcontrast T1 maps for the detection of cardiac amyloidosis in a large patient sample. This retrospective study included consecutive patients who underwent MRI-derived extracellular volume fraction (MRI ECV) analysis between March 2017 and July 2021 because of known or suspected heart failure or cardiomyopathy. Pre- and postcontrast T1 maps were generated using the modified Look-Locker inversion recovery sequence. Diagnostic performances of MRI ECV and myocardium-to-lumen R1 ratio on postcontrast T1 maps (a simplified index not requiring a native T1 map and hematocrit level data) for detecting cardiac amyloidosis were evaluated using the area under the receiver operating characteristic curve (AUC), sensitivity, and specificity. Of 352 patients (mean age, 63 years ± 16 [SD]; 235 men), 136 had cardiac amyloidosis. MRI ECV showed 89.0% (121 of 136; 95% CI: 82%, 94%) sensitivity and 98.6% (213 of 216; 95% CI: 96%, 100%) specificity for helping detect cardiac amyloidosis (cutoff value of 40% [AUC, 0.99 {95% CI: 0.97, 1.00}; Postcontrast myocardium-to-lumen R1 ratio showed excellent diagnostic performance comparable to that of MRI ECV in the detection of cardiac amyloidosis.
Identifiants
pubmed: 37124644
doi: 10.1148/ryct.220327
pmc: PMC10141336
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e220327Informations de copyright
© 2023 by the Radiological Society of North America, Inc.
Déclaration de conflit d'intérêts
Disclosures of conflicts of interest: M.K. Belongs to the endowed department at Kumamoto University funded by donations from Philips Healthcare. S.O. No relevant relationships. S.T. No relevant relationships. Y.K. No relevant relationships. H.H. No relevant relationships. K.M. No relevant relationships. T.E. No relevant relationships. S.S. No relevant relationships. F.Y. No relevant relationships. T.N. No relevant relationships. Y.N. No relevant relationships. M.M. No relevant relationships. M.U. Research grants from Pfizer and Alnylam Pharmaceuticals; honoraria for lectures from Pfizer and Alnylam Pharmaceuticals. K.T. No relevant relationships. T.H. Research support from Philips Healthcare.
Références
Circ Cardiovasc Imaging. 2021 Jun;14(6):e009025
pubmed: 34129344
JACC Cardiovasc Imaging. 2013 Apr;6(4):488-97
pubmed: 23498672
J Cardiovasc Magn Reson. 2016 Nov 30;18(1):89
pubmed: 27899132
Radiology. 2023 Mar;306(3):e222406
pubmed: 36255317
JACC Cardiovasc Imaging. 2020 Jan;13(1 Pt 1):69-80
pubmed: 31202744
J Magn Reson Imaging. 2021 May;53(5):1458-1468
pubmed: 33274809
JACC Cardiovasc Imaging. 2019 Nov;12(11 Pt 2):2345-2356
pubmed: 31422120
Eur Heart J. 2021 Apr 21;42(16):1554-1568
pubmed: 33825853
Radiographics. 2020 Jul-Aug;40(4):961-981
pubmed: 32442047
JACC Cardiovasc Imaging. 2016 Jan;9(1):14-23
pubmed: 26684970
JACC Cardiovasc Imaging. 2020 Jun;13(6):1299-1310
pubmed: 32498919
Nat Rev Cardiol. 2020 Jul;17(7):413-426
pubmed: 32042139
Circ Cardiovasc Imaging. 2013 Jan 1;6(1):34-9
pubmed: 23192846
J Cardiovasc Magn Reson. 2017 Oct 9;19(1):75
pubmed: 28992817
JACC Cardiovasc Imaging. 2016 Jan;9(1):64-6
pubmed: 26762876
Circulation. 2016 Jun 14;133(24):2404-12
pubmed: 27143678
JACC Cardiovasc Imaging. 2009 Dec;2(12):1369-77
pubmed: 20083070
Heart. 2006 Mar;92(3):343-9
pubmed: 15939726
Magn Reson Med. 2014 Jun;71(6):2082-95
pubmed: 23881866
J Cardiovasc Magn Reson. 2011 Mar 04;13:16
pubmed: 21375743
JACC Cardiovasc Imaging. 2022 Apr;15(4):700-704
pubmed: 34023257
Circulation. 2005 Jan 18;111(2):186-93
pubmed: 15630027
JACC Cardiovasc Imaging. 2020 Jun;13(6):1368-1383
pubmed: 31607664
J Intern Med. 2015 May;277(5):605-14
pubmed: 25346163
Circ Cardiovasc Imaging. 2022 Apr;15(4):e013745
pubmed: 35360924
J Magn Reson Imaging. 2007 Jun;25(6):1283-7
pubmed: 17520735
Insights Imaging. 2022 Mar 26;13(1):55
pubmed: 35348907
Int J Cardiovasc Imaging. 2018 Nov;34(11):1769-1777
pubmed: 29846837
J Magn Reson Imaging. 2011 Jul;34(1):50-5
pubmed: 21698706
Circ Cardiovasc Imaging. 2021 Jul;14(7):e000029
pubmed: 34196223
JACC Cardiovasc Imaging. 2016 Jan;9(1):54-63
pubmed: 26762875
Radiology. 2023 Mar;306(3):e220542
pubmed: 36255307
JACC Cardiovasc Imaging. 2019 Nov;12(11 Pt 2):2305-2318
pubmed: 31422140
JACC Cardiovasc Imaging. 2020 Oct;13(10):2177-2189
pubmed: 32771574
JACC Cardiovasc Imaging. 2019 May;12(5):810-819
pubmed: 29550324
J Cardiovasc Magn Reson. 2018 Aug 9;20(1):56
pubmed: 30089499